Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to GENITOURINARY CANCER

Oncology Learning Network

PARP Inhibitors as Treatment Options for Monotherapy and Combination Therapy in HRRm or BRCAm Prostate Cancer

Oncology, Medical April 29th 2025

Cancer Therapy Advisor

ASCO GU 2024: Advances in Prostate Cancer

Oncology, Medical February 20th 2024

Oncology News Central (ONC)

A Tale of Two ICIs: Adjuvant Pembro Ups Survival in RCC, Nivo Doesn’t

Oncology, Medical February 5th 2024

Renal & Urology News

Lymphovascular Invasion Ups Mortality Risk in Kidney Cancer Surgery Cases

Oncology, Medical September 5th 2023

Cancer Therapy Advisor

Report From ASCO 2023: Centering on the Patient and Focusing on GU Cancers

Hematology/Oncology August 29th 2023

Cancer Therapy Advisor

Systemic Therapy for Nonmetastatic Castration-Resistant Prostate Cancer

Oncology, Medical July 18th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form